Skip to main content
Signal8

Moriarty John B

SEC insider (Form 3/4/5 filer). CIK 0001564621. Chief Legal Officer at Kardigan, Inc. (KARD) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in PRINCETON, NJ.

Companies Moriarty John B has filed insider reports for

  • Kardigan, Inc. (KARD): Officer, Chief Legal Officer
  • Avidity Biosciences, Inc. (RNAM): Officer, Chief Legal Officer
Moriarty John B profile photo

Moriarty John B

CIK: 0001564621

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Kardigan, Inc. logo
KARD

Kardigan, Inc.

Officer
Avidity Biosciences, Inc. logo
RNAM

Avidity Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Kardigan, Inc. logo
    KARD

    Kardigan, Inc.

    Jun 17, 2026
    Award
    Direct
    47.8K shares-
  • Avidity Biosciences, Inc. logo
    RNAM

    Avidity Biosciences, Inc.

    Feb 27, 2026
    Disposition
    Direct
    92.1K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jan 7, 2026
    Sale
    Direct
    2.4K shares at avg. $72.23$171K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Dec 17, 2025
    Award
    Direct
    56K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Dec 17, 2025
    Tax Payment
    Direct
    26.8K shares at avg. $71.87$1.9M
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Aug 4, 2025
    Sale
    Direct
    2.2K shares at avg. $36.21$81K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jan 6, 2025
    Award
    Direct
    25K shares-

1-7 of 7